美国 · SEC FORM 4
BioAtla, Inc.
BCAB · OTC · CIK 0001826892 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
6 同一窗口内观察到的 Form 4 交易行
0 sales · 6 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-12-26 · MCBRINN SYLVIA.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -45.8%
- 3M
- -67.1%
- 6M
- -73.5%
- 12M
- -96.8%
波动率与流动性
- 波动率
- 139.1%
- Beta
- —
- 平均每日成交额
- USD 75,829
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- —
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-15 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 75,558
- 上期报告
- 94,060
- 日均成交量
- 54,698
- 回补天数
- 1.4
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2023-12-26 | MCBRINN SYLVIA | 买入 (P) | Common Stock | 4,000 | USD 2.33 | USD 9,320 | SEC 申报 ↗ |
| 2023-12-20 | SHORT JAY M PHD | 买入 (P) | Common Stock | 50,000 | USD 2.14 | USD 107,000 | SEC 申报 ↗ |
| 2023-12-19 | Vasquez Christian | 买入 (P) | Common Stock | 7,495 | USD 2.04 | USD 15,290 | SEC 申报 ↗ |
| 2023-12-19 | STEINMAN LAWRENCE | 买入 (P) | Common Stock | 20,000 | USD 2.05 | USD 41,000 | SEC 申报 ↗ |
| 2023-09-08 | MCBRINN SYLVIA | 买入 (P) | Common Stock | 2,000 | USD 2.54 | USD 5,080 | SEC 申报 ↗ |
| 2023-03-29 | SHORT JAY M PHD | 买入 (P) | Common Stock | 40,800 | USD 2.47 | USD 100,776 | SEC 申报 ↗ |
| 2023-03-28 | MCBRINN SYLVIA | 买入 (P) | Common Stock | 4,000 | USD 2.35 | USD 9,400 | SEC 申报 ↗ |
| 2023-03-28 | Vasquez Christian | 买入 (P) | Common Stock | 20,000 | USD 2.40 | USD 48,000 | SEC 申报 ↗ |
| 2022-12-19 | MCBRINN SYLVIA | 买入 (P) | Common Stock | 3,700 | USD 8.33 | USD 30,821 | SEC 申报 ↗ |
| 2022-11-22 | MCBRINN SYLVIA | 买入 (P) | Common Stock | 2,000 | USD 8.27 | USD 16,540 | SEC 申报 ↗ |
| 2022-09-13 | MCBRINN SYLVIA | 买入 (P) | Common Stock | 1,000 | USD 8.20 | USD 8,200 | SEC 申报 ↗ |
| 2022-09-12 | MCBRINN SYLVIA | 买入 (P) | Common Stock | 2,000 | USD 8.85 | USD 17,700 | SEC 申报 ↗ |
| 2022-08-12 | SHORT JAY M PHD | 买入 (P) | Common Stock | 26,350 | USD 7.84 | USD 206,584 | SEC 申报 ↗ |
| 2022-06-22 | SHORT JAY M PHD | 买入 (P) | Common Stock | 40,308 | USD 2.91 | USD 117,296 | SEC 申报 ↗ |
| 2022-06-21 | SHORT JAY M PHD | 买入 (P) | Common Stock | 29,082 | USD 2.79 | USD 81,139 | SEC 申报 ↗ |
Form 4 申报证据
17 transaction lines in the latest 365-day window; 333 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Vasquez Christian | 代扣税 (F) | Common Stock | 71 | USD 1.69 | USD 120 | SEC 申报 ↗ |
| 2026-08-31 | Sievers Eric | 代扣税 (F) | Common Stock | 134 | USD 1.69 | USD 226 | SEC 申报 ↗ |
| 2026-08-31 | SHORT JAY M PHD | 代扣税 (F) | Common Stock | 259 | USD 1.69 | USD 438 | SEC 申报 ↗ |
展开近期 Form 4 证据 (17 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-31 | Vasquez Christian | 代扣税 (F) | Common Stock | 71 | USD 1.69 | USD 120 | SEC 申报 ↗ |
| 2026-08-31 | Sievers Eric | 代扣税 (F) | Common Stock | 134 | USD 1.69 | USD 226 | SEC 申报 ↗ |
| 2026-08-31 | SHORT JAY M PHD | 代扣税 (F) | Common Stock | 259 | USD 1.69 | USD 438 | SEC 申报 ↗ |
| 2026-05-31 | Vasquez Christian | 代扣税 (F) | Common Stock | 82 | USD 3.93 | USD 322 | SEC 申报 ↗ |
| 2026-05-31 | Sievers Eric | 代扣税 (F) | Common Stock | 134 | USD 3.93 | USD 527 | SEC 申报 ↗ |
| 2026-05-31 | SHORT JAY M PHD | 代扣税 (F) | Common Stock | 259 | USD 3.93 | USD 1,018 | SEC 申报 ↗ |
| 2026-03-11 | SHORT JAY M PHD | 奖励／授予 (A) | Common Stock | 430,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | Vasquez Christian | 奖励／授予 (A) | Common Stock | 240,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-10 | Sievers Eric | 奖励／授予 (A) | Common Stock | 240,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-28 | WALDRON RICHARD A | 代扣税 (F) | Common Stock | 2,729 | USD 0.25 | USD 682 | SEC 申报 ↗ |
| 2026-02-28 | Vasquez Christian | 代扣税 (F) | Common Stock | 1,802 | USD 0.25 | USD 450 | SEC 申报 ↗ |
| 2026-02-28 | Sievers Eric | 代扣税 (F) | Common Stock | 3,140 | USD 0.25 | USD 785 | SEC 申报 ↗ |
| 2026-02-28 | SHORT JAY M PHD | 代扣税 (F) | Common Stock | 7,728 | USD 0.25 | USD 1,932 | SEC 申报 ↗ |
| 2025-11-30 | WALDRON RICHARD A | 代扣税 (F) | Common Stock | 2,371 | USD 0.90 | USD 2,134 | SEC 申报 ↗ |
| 2025-11-30 | Vasquez Christian | 代扣税 (F) | Common Stock | 1,566 | USD 0.90 | USD 1,409 | SEC 申报 ↗ |
| 2025-11-30 | Sievers Eric | 代扣税 (F) | Common Stock | 2,729 | USD 0.90 | USD 2,456 | SEC 申报 ↗ |
| 2025-11-30 | SHORT JAY M PHD | 代扣税 (F) | Common Stock | 6,347 | USD 0.90 | USD 5,712 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BCAB |
| CIK | 0001826892 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| 交易所 | OTC |
数据覆盖
| 本地 Form 4 历史 | 333 transaction lines from 2020-12-18 to 2026-08-31 21 P purchase lines · 104 S sale lines · 208 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.